Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.853
H.R.853: Closing Loopholes for Orphan Drugs Act
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced Feb. 4, 2021
- Latest Major Action Feb. 5, 2021
- See the three similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsor
Bill Version
- Introduced in House - Feb. 4, 2021
Bill Summary
Closing Loopholes for Orphan Drugs Act This bill revises the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (i.e., drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program.
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Feb. 5, 2021 |
Referred to the Subcommittee on Health.
|
Feb. 4, 2021 |
Referred to the House Committee on Energy and Commerce.
|
Feb. 4, 2021 |
Introduced in the House by Peter Welch (D-Vt.) |